In recent years, with the rapid growth of the herbal medicine industry and the increasing involvement of health-based startups, the process of obtaining licenses from the Iran Food and Drug Administration (FDA) has become a key focus.
Iran FDA Enhances Transparency in Licensing Process for Herbal Products
In recent years, with the rapid growth of the herbal medicine industry and the increasing involvement of health-based startups, the process of obtaining licenses from the Iran Food and Drug Administration (FDA) has become a key focus. According to the latest official statements, the Iran FDA is reviewing and updating its procedures to simplify and accelerate the evaluation of herbal product dossiers.
Experts believe that one of the main causes of delays in licensing is the lack of complete or accurate documentation submitted by companies. To address this, the Iran FDA is improving its digital systems and online platforms to streamline communication with applicants.
Technology companies, accelerators, and incubators are playing a critical role in empowering innovative teams by educating them on compliance and documentation. Ensuring transparency in compiling scientific data, conducting safety and efficacy studies, designing proper packaging, and adhering to GMP standards are essential steps in the process.
These regulatory improvements aim to create a secure path for herbal innovations to enter the health market and boost their potential for international export.
